Inflammatory Bowel Disease
Q&A: ‘Everyone benefits’ from noninvasive, individualized monitoring in pediatric IBD
SAN FRANCISCO — Noninvasive monitoring methods, such as enterography and ultrasound, are becoming increasingly recognized as essential tools in the management of pediatric patients with inflammatory bowel disease, according to presenters.
Oral vancomycin may offer ‘viable option’ for IBD-related primary sclerosing cholangitis
Oral vancomycin therapy resulted in clinical response in nearly half of patients with inflammatory bowel disease associated with primary sclerosing cholangitis, according to a study published in Therapeutic Advances in Gastroenterology.
VIVID-2: Omvoh demonstrates ‘continued durability,’ safety in Crohn’s disease at 2 years
SAN FRANCISCO — Most patients with moderately to severely active Crohn’s disease who achieved endoscopic response and remission after 52 weeks of Omvoh therapy maintained those results through 104 weeks, according to VIVID-2 study results.
Train support staff to be aware of mental health concerns in IBD to avoid future trauma
SAN FRANCISCO — Patients with inflammatory bowel disease remain at higher risk for mental health disorders, but training support staff to recognize the symptoms could be key to preventing further traumatization, noted a presenter here.
Most patients with IBD ‘still experience significant challenges’ accessing, affording care
SAN FRANCISCO — Despite advances in treatment for inflammatory bowel disease, more than 55% of patients report medication delays, mostly due to insurance challenges, and many make financial trade-offs to afford care, survey results showed.
‘Lack of patient activation’ in pediatric IBD may be poor health literacy in disguise
SAN FRANCISCO — Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming health disparities among pediatric patients with inflammatory bowel disease, noted a presenter.
Q&A: IBD wearable alerts patients ‘in real time’ about impending disease flares
SAN FRANCISCO — IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease monitoring by continuously measuring biomarkers in sweat, according to the creators of the device.
Higher rates of preterm delivery, low birthweight observed with IBD in twin pregnancies
Women with inflammatory bowel disease who delivered a twin gestation pregnancy had higher rates of preterm delivery and infants born small for gestational age or with low birthweight compared with healthy controls, according to research.
IBD, several GI cancers join growing list of risks for patients with celiac disease
A French cohort study confirmed high risks for lymphoma and small bowel cancer in patients with celiac disease but also found elevated risks for pancreatic, esophageal, gastric and colonic cancers, as well as inflammatory digestive diseases.
IBD drug market rattles as Lilly’s Omvoh nabs FDA approval for second IL-23p19 in Crohn’s
The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second interleukin-23p19 specific inhibitor approved for both major types of inflammatory bowel disease, Lilly reported.